These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10496963)

  • 1. The importance of a nitrogen atom in modulators of multidrug resistance.
    Ecker G; Huber M; Schmid D; Chiba P
    Mol Pharmacol; 1999 Oct; 56(4):791-6. PubMed ID: 10496963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
    Chiba P; Ecker G; Schmid D; Drach J; Tell B; Goldenberg S; Gekeler V
    Mol Pharmacol; 1996 Jun; 49(6):1122-30. PubMed ID: 8649352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies on benzofuran analogs of propafenone-type modulators of tumor cell multidrug resistance.
    Ecker G; Chiba P; Hitzler M; Schmid D; Visser K; Cordes HP; Csöllei J; Seydel JK; Schaper KJ
    J Med Chem; 1996 Nov; 39(24):4767-74. PubMed ID: 8941391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro multidrug resistance modulating activity of a series of dihydrobenzopyrans and tetrahydroquinolines.
    Hiessböck R; Wolf C; Richter E; Hitzler M; Chiba P; Kratzel M; Ecker G
    J Med Chem; 1999 Jun; 42(11):1921-6. PubMed ID: 10354400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A subset of highly effective propafenone-type multidrug resistance modulators lacks effects on cardiac action potential and mechanical twitch parameters of rat papillary muscles.
    Schmid D; Staudacher DL; Loew HG; Spieckermann PG; Ecker GF; Kopp S; Chiba P
    J Pharmacol Exp Ther; 2003 Nov; 307(2):589-96. PubMed ID: 12966158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and multidrug-resistance modulating activity of a series of thienothiazines.
    Chiba P; Erker T; Galanski M; Hitzler M; Ecker GF
    Arch Pharm (Weinheim); 2002 May; 335(5):223-8. PubMed ID: 12210779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein.
    Kang CD; Ahn BK; Jeong CS; Kim KW; Lee HJ; Yoo SD; Chung BS; Kim SH
    Exp Cell Res; 2000 Apr; 256(1):300-7. PubMed ID: 10739677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chalcogenopyrylium dyes as inhibitors/modulators of P-glycoprotein in multidrug-resistant cells.
    Sawada GA; Raub TJ; William Higgins J; Brennan NK; Moore TM; Tombline G; Detty MR
    Bioorg Med Chem; 2008 Nov; 16(22):9745-56. PubMed ID: 18849167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements.
    Schmid D; Ecker G; Kopp S; Hitzler M; Chiba P
    Biochem Pharmacol; 1999 Nov; 58(9):1447-56. PubMed ID: 10513988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (+/-)-3'-O, 4'-O-dicynnamoyl-cis-khellactone, a derivative of (+/-)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells.
    Shen X; Chen G; Zhu G; Fong WF
    Bioorg Med Chem; 2006 Nov; 14(21):7138-45. PubMed ID: 16875827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of dihydropyrroloquinolines that selectively antagonize P-glycoprotein.
    Lee BD; Li Z; French KJ; Zhuang Y; Xia Z; Smith CD
    J Med Chem; 2004 Mar; 47(6):1413-22. PubMed ID: 14998330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
    Eckford PD; Sharom FJ
    Biochemistry; 2008 Dec; 47(51):13686-98. PubMed ID: 19049391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional quantitative structure-activity relationship analysis of propafenone-type multidrug resistance modulators: influence of variable selection on test set predictivity.
    Fleischer R; Wiese M
    J Med Chem; 2003 Nov; 46(23):4988-5004. PubMed ID: 14584949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OC144-093, a novel P glycoprotein inhibitor for the enhancement of anti-epileptic therapy.
    Newman MJ; Dixon R; Toyonaga B
    Novartis Found Symp; 2002; 243():213-26; discussion 226-30, 231-5. PubMed ID: 11990779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
    Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
    FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological evaluation, structure-activity relationships, and three-dimensional quantitative structure-activity relationship studies of dihydro-beta-agarofuran sesquiterpenes as modulators of P-glycoprotein-dependent multidrug resistance.
    Reyes CP; Muñoz-Martínez F; Torrecillas IR; Mendoza CR; Gamarro F; Bazzocchi IL; Núñez MJ; Pardo L; Castanys S; Campillo M; Jiménez IA
    J Med Chem; 2007 Oct; 50(20):4808-17. PubMed ID: 17850057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P glycoprotein and the mechanism of multidrug resistance.
    Váradi A; Szakács G; Bakos E; Sarkadi B
    Novartis Found Symp; 2002; 243():54-65; discussion 65-8, 180-5. PubMed ID: 11990782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, pharmacologic activity, and structure-activity relationships of a series of propafenone-related modulators of multidrug resistance.
    Chiba P; Burghofer S; Richter E; Tell B; Moser A; Ecker G
    J Med Chem; 1995 Jul; 38(14):2789-93. PubMed ID: 7629817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
    Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
    Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.